South China Morning Post
ByteDance spin-off Anew Labs raises US$290m as AI drug developers enjoy fundraising boom
China is seeing a fresh fundraising boom for AI drug developers, with start-ups including a ByteDance spin-off raising hundreds of millions of dollars this week as investors rush to back domestic challengers to Anthropic and Isomorphic…
View original source — South China Morning Post ↗
Related stories
The Next Web
TechnologySep 16, 2026 · 1 min
ByteDance’s AI drug unit Anew Labs raises $290M at $1.5B valuation, Reuters reports
The Next Web
South China Morning Post
TechnologySep 13, 2026 · 1 min
Seeking cash for AI, China’s Z.ai eyes new US$5b fundraising push after July share sale
South China Morning Post
South China Morning Post
TechnologySep 3, 2026 · 1 min
Mainland Chinese investors buy Hong Kong tech stocks in AI pivot, sell financials
South China Morning Post
The Next Web
TechnologySep 17, 2026 · 1 min
Former DeepMind world-model researchers’ startup Emulate in talks to raise $700M
The Next Web